Syndax Announces $35.0 Million Offering of Common Stock and Enters Term Sheet for Loan with Hercules Capital for up to $30 Million
- Friday, January 31, 2020, 7:15
- Environment
- Add a comment
WALTHAM, Mass., Jan. 31, 2020 /PRNewswire/ — Syndax Pharmaceuticals, Inc. (“Syndax,” the “Company” or “we”) (Nasdaq:SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that it has entered into an agreement with five…
About the Author
adminasapcorp has written 41523 stories on this site.